Roseola overview: Difference between revisions

Jump to navigation Jump to search
Line 47: Line 47:


=== Electrocardiogram ===
=== Electrocardiogram ===
There are no electrocardiogram findings associated with roseola.


=== Chest X Ray ===
=== Chest X Ray ===

Revision as of 20:04, 30 May 2017

Roseola Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Roseola from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Roseola overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Roseola overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Roseola overview

CDC on Roseola overview

Roseola overview in the news

Blogs on Roseola overview

Directions to Hospitals Treating Type chapter name here

Risk calculators and risk factors for Roseola overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omodamola Aje B.Sc, M.D. [2]

Overview

Roseola is a disease of infants. It is characterized by an abrupt rise in body temperature to as high as 40°C (104°F) followed by a rapid drop to normal within the next 2–4 days which coincides with the appearance of an erythematous maculopapular skin rash that persists for 1–3 days. It is typically a beningn disease which resolves without sequalae. Roseola disease is caused by Human herpes virus 6 (HHV6). HHV-6 is a member of the Herpesvirales order, Herpesviridae family, Betaherpesvirinae subfamily, and Roseolovirus genus. HHV-6A and HHV-6B are two distinct species of HHV-6.

Historical perspective

Human herpes virus 6 was first identified in 1986. Herpesviruses have a unique four-layered structure: a core containing the large, double-stranded DNA genome is enclosed by an icosapentahedral capsid which is composed of capsomers. The capsid is surrounded by an amorphous protein coat called the tegument. It is encased in a glycoprotein-bearing lipid bilayer envelope.

Classification

There is no established classification system for roseola.

Pathophysiology

Primary infection with HHV-6 has been shown to be the cause of exanthem subitum (roseola) in infants and can also result in an infectious mononucleosis-like illness in adults.

Causes

Roseola is caused by Human herpes virus 6, a member of the Herpesvirales order, Herpesviridae family, Betaherpesvirinae subfamily, and Roseolovirus genus. Herpesviruses have a unique four-layered structure: a core containing the large, double-stranded DNA genome is enclosed by an icosapentahedral capsid which is composed of capsomers. The capsid is surrounded by an amorphous protein coat called the tegument. It is encased in a glycoprotein-bearing lipid bilayer envelope.

Differential diagnosis

Roseola must be differentiated from other diseases that cause fever and rash, such as Rubella (german measles), Rubeola (measles), hand foot and mouth disease caused by coxakie virus, erythema infectiosum caused by parvovirus B19, scarlet fever and even drug allergy.

Epidemiology and demographics

Roseola is an illness of young children, with a peak prevalence between 7 and 13 months. Ninety percent of cases occur in children younger than two years. Roseola occurs equally in boys and girls. It occurs throughout the year, although outbreaks may occur in groups according to season .

Risk factors

The common risk factor in the development of roseola is infancy: 6 - 15 months.

Screening

According to the USPSTF, there is insufficient evidence to recommend routine screening for roseola.

Natural history complications and prognosis

The symptoms of roseola usually starts in the first 2 years of life of an infant. It starts as a high fever 40ºC (104ºF) which lasts for 3 to 5 days, as the fever abates, the child develops a non pruritic blanching papular or maculopapular rash that starts on the neck and progresses downward.

Diagnosis

History and Symptoms

The hallmark of roseola is a non pruritic macular or maculopapular rash rash. A positive history of a high fever of 40ºC (104ºF) that lasts for 3 to 5 days.

Physical Examination

Patients are usually well appearing depending on the time of presentation, patient may present in the febrile or rash phase, in distress or not.

Laboratory Findings

The diagnosis of roseola is made clinically. However, in atypical cases, the diagnosis can be made by both serologic and direct detection of HHV6 virus in the saliva of the patient. Expected results of diagnostic studies include antigen detection, PCR, and immunofluorescence.

Electrocardiogram

There are no electrocardiogram findings associated with roseola.

Chest X Ray

MRI

Echocardiography or ultrasound

Other imaging findings

Other diagnostic studies

Treatment

Medical therapy

Surgery

Primary prevention

Secondary prevention

Cost Effectiveness of Therapy

Future investigational Therapies

References